Latest News
News Archived
Feb
14
2014
Enzymatics Launches Archer™ NGS
Marco Island, Fla.––February 14, 2014––Enzymatics, Inc., a leading producer of molecular biology reagents, kits, assays and software, today unveils Archer™ Targeted Sequencing technology, which dramatically enhances gene mutation identification and discovery with high sensitivity and reduced costs. The technology is being announced during the Advances in Genome Biology & Technology (AGBT) conference, which is recognized throughout the sequencing community as a cornerstone for the discussion of genomics research. Continue Reading »
Download PDFJan
14
2014
Annoucement of Next Generation Sequencing Workshop
Enzymatics, Inc., Gold Sponsor of the 15th annual Advances in Genome Biology and Technology (AGBT) meeting held in Marco Island, Florida, will be hosting a workshop February 14, 2014 on Targeted Next Generation Sequencing for Oncology. The workshop will feature speakers Long Le, MD, PhD from Massachusetts General Hospital; Niall Lennon, PhD from Broad Institute; Continue Reading »
Download PDFDec
04
2013
Announcement of Gold Sponsorship for AGBT
Enzymatics, Inc., a leading producer of reagents, kits, and assays, is proud to be the Gold Sponsor of the 15th annual Advances in Genome Biology and Technology (AGBT) meeting held in Marco Island, Florida, on February 12-15, 2014. AGBT is well recognized as a cornerstone for the genomics community, and continuously provides a forum for Continue Reading »
Sep
06
2013
Enzymatics Acquires ArcherDx and Next-Generation Diagnostic Technology
Enzymatics a leading producer of reagents, kits, and assays, today announced it has acquired Boulder-based ArcherDx, Inc., a developer of innovative, NGS-based kits and software solutions for use in investigating cancer treatment. Continue Reading »
Download PDFJun
11
2013
Announcement of Dropped Infringement Claim
Enzymatics, Inc., a rapidly growing provider of molecular biology reagents, today announced that patent infringement claims filed against the company by New England BioLabs (NEB) have been significantly narrowed. Continue Reading »
Download PDFMay
29
2013
Enzymatics Launches SPARK™ DNA Sample Prep Kits
Enzymatics, Inc., a rapidly growing provider of molecular biology reagents, announced today the launch of SPARK™ DNA Sample Prep Kits for Illumina® and Ion Torrent™ Continue Reading »
Download PDFMar
14
2013
Announcement of Temperature Library Construction Kits
Enzymatics, Inc., (www.enzymatics.com) announced that, in collaboration with scientists from UT Austin (including Dr. Andrew Ellington) it has developed a portfolio of Room Temperature Stable Library Construction Kits for the Illumina sequencing platform and is developing kits for the Ion Torrent platform. Continue Reading »
Download PDFSep
04
2012
Jonathan DiVincenzo Joins Enzymatics as President & CEO
Enzymatics, Inc., a rapidly growing provider of molecular biology reagents, today announced the appointment of Jonathan DiVincenzo as President and Chief Executive Officer. Continue Reading »
Download PDFAug
02
2011
Enzymatics Honored with Award
Enzymatics, Inc., has been honored by the Greater Boston Chamber of Commerce with a “Top 10 Small Business” of the year award for 2011. Continue Reading »
Download PDFMar
16
2009
Announcement of Certifications
Beverly, MA, (March 16th, 2009) Enzymatics, specialists in the development, manufacture, and distribution of analytical grade molecular biology enzymes for the research and diagnostic markets, has been awarded certification to the ISO 13485:2003 and 9001:2000 standards by certification body TÜV SÜD America. Enzymatics is focused on the development, production, and support of proteins for use Continue Reading »
Back to top
Location
QIAGEN Beverly
100 Cummings Center
Suite 407J
Beverly, MA 01915